No insider purchase over the last 90 days. The latest was filed 24 May 2026.
Micropos Medical AB (publ), classified in the Health Care sector, is a listed company. Its insiders report their share dealings to Finansinspektionen. Over the twelve months to 18 October 2026, 3 filings were filed, from 2 insiders.
Not one open-market sale was filed. On the buying side, 1 insider reported 1 purchase totalling €678k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The buyers include 1 board member. Ove Mattsson filed the largest purchase, €678k, on 24 May 2026.
For context, the typical company on the same exchange (median of 886 companies) published 8 filings over the same period, against 3 filings here. Looking back to 2026, when coverage begins, insiders filed 1 purchase and no sales.
The most recent open-market purchase was published on 24 May 2026, 147 days ago. Typically, a trade is published a median of 2 days after it takes place. Under the Market Abuse Regulation, managers have three business days to notify their trades.
Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Anixa Biosciences Inc. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
· cache
3 of 3 declarations
Micropos Medical AB (publ) is a Swedish company operating in the healthcare and pharmaceutical sector. It is listed on the Stockholm Stock Exchange (XSTO).
Purchases our model currently ranks for the recommendations list.
All recommendations